AP
Their report — an analysis of 136 studies — suggests that in some cases, the drastic operations may alter the patient's body chemistry itself and relieve conditions that can lead to heart attacks, strokes and kidney failure.
The analysis was funded by a Johnson & Johnson Co. subsidiary that develops and markets surgical instruments, including staplers for obesity surgery. But the results echo what many doctors have reported seeing.
More...
|